Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in the role of sphingosine 1‐phosphate in cancer
Nigel J. Pyne, Susan Pyne
FEBS Letters (2020) Vol. 594, Iss. 22, pp. 3583-3601
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
Samar Sami Alkafaas, Mohamed I. Elsalahaty, Doha F. Ismail, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 26
The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy
Megan A. Sheridan, Besim Öğretmen
Cancers (2021) Vol. 13, Iss. 10, pp. 2475-2475
Open Access | Times Cited: 66
Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer
Michela Codini, Mercedes Garcia‐Gil, Elisabetta Albi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 726-726
Open Access | Times Cited: 60
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
Alhaji H. Janneh, Besim Öğretmen
Cancers (2022) Vol. 14, Iss. 9, pp. 2183-2183
Open Access | Times Cited: 45
Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets
Miguel L. Rufail, Rosaria Bassi, Paola Giussani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1056-1056
Open Access | Times Cited: 1
Epithelial-mesenchymal Transition Promotes Metabolic Reprogramming to Suppress Ferroptosis
Wenzheng Guo, Zhibing Duan, Jingjing Wu, et al.
Seminars in Cancer Biology (2025)
Closed Access | Times Cited: 1
The Functional Role of Sphingosine Kinase 2
Rocio Diaz Escarcega, Louise D. McCullough, Andrey S. Tsvetkov
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 43
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
Yanhong Bu, Hong Wu, Ran Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 43
Sphingosine 1-phosphate signaling during infection and immunity
Sabira Mohammed, A. R. Bindu, Viswanathan Arun, et al.
Progress in Lipid Research (2023) Vol. 92, pp. 101251-101251
Closed Access | Times Cited: 19
Inhibitory Effect of Astragalus Polysaccharide on Premetastatic Niche of Lung Cancer through the S1PR1‐STAT3 Signaling Pathway
Ming Shen, Yan-jun Wang, Zhao-hua Liu, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 14
The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response
Paola Antonia Corsetto, Stefania Zava, Angela Maria Rizzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2107-2107
Open Access | Times Cited: 13
S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway
Yi-Ping Tao, Heng-Yan Zhu, Qian-Yuan Shi, et al.
Oncogene (2023) Vol. 42, Iss. 47, pp. 3491-3502
Open Access | Times Cited: 13
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
Zhong-Chen Li, Jie Wang, He-Bin Liu, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113877-113877
Open Access | Times Cited: 4
Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
David Chamoso‐Sánchez, Michela Panini, Clarissa Caroli, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones
Ryan D. Kruschel, Kyle Malone, Aileen Walsh, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 268-268
Open Access
Leveraging altered lipid metabolism in treating B cell malignancies
Jae Woong Lee, Arya Mani, Min‐Jeong Shin, et al.
Progress in Lipid Research (2024) Vol. 95, pp. 101288-101288
Open Access | Times Cited: 3
miRNA506 Activates Sphk1 Binding with Sirt1 to Inhibit Brain Injury After Intracerebral Hemorrhage via PI3K/AKT Signaling Pathway
Tianyu Liang, Renyang Liu, Jinquan Liu, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Ceramide Metabolism Enzymes—Therapeutic Targets against Cancer
Ana Gómez-Larrauri, Upasana Das Adhikari, Marta Aramburu-Núñez, et al.
Medicina (2021) Vol. 57, Iss. 7, pp. 729-729
Open Access | Times Cited: 22
Ultrasound-stimulated microbubbles enhanced vascular disruption in fractionated radiotherapy-treated tumours via ASMase activation
Kai Xuan Leong, Wen‐Yi Yang, Deepa Sharma, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 6
Open Access | Times Cited: 8
S1P-Induced TNF-α and IL-6 Release from PBMCs Exacerbates Lung Cancer-Associated Inflammation
Michela Terlizzi, Chiara Colarusso, Pasquale Somma, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2524-2524
Open Access | Times Cited: 12
Role for CCN1 in lysophosphatidic acid response in PC‐3 human prostate cancer cells
Pravita Balijepalli, Brianna K. Knode, Samuel A. Nahulu, et al.
Journal of Cell Communication and Signaling (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
A Crosstalk between the Receptor Tyrosine Kinase-Like Orphan Receptors ROR1/2 and S1P Signaling Pathways in Lung Cancer
Rajeev Nema, Ritu Pandey, Ashok Kumar
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 3, pp. 725-733
Open Access | Times Cited: 2
Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells
Rajeev Nema, Ashok Kumar
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 15
Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion
Stephanie L. E. Compton, Joseph P. Grieco, Benita Gollamudi, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1399-1399
Open Access | Times Cited: 11
Nephrotoxicity in cancer treatment: An update
Chaoling Chen, Dengpiao Xie, David A. Gewirtz, et al.
Advances in cancer research (2022), pp. 77-129
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top